AI Science Tracker
EN

Models including preoperative plasma levels of angiogenic factors, leptin and IL-8 as potential biomarkers of endometrial cancer

Department of Gynaecology and Obstetrics, Faculty of Medicine, University of Ljubljana, Slovenia · 24 Nov 2022 · medicine

Discovery

Models including preoperative plasma levels of angiogenic factors, leptin and IL-8 as potential biomarkers of endometrial cancer

Source check: Source checked. Not independent scientific confirmation.

Finding: The model reports ROC AUC 0.89 on training and held-out test data from prospective clinical sampling. This is a single-center result requiring multicenter confirmation; prospective sampling does not establish clinical benefit.

Technology: A machine-learning classifier combines preoperative plasma angiogenic-factor, leptin and IL-8 measurements to predict endometrial cancer.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
A machine-learning classifier combines preoperative plasma angiogenic-factor, leptin and IL-8 measurements to predict endometrial cancer.
Test and result
The model reports ROC AUC 0.89 on training and held-out test data from prospective clinical sampling.
Limitation / still unknown
This is a single-center result requiring multicenter confirmation; prospective sampling does not establish clinical benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.972131/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.